These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4545376)

  • 41. An analysis of the dose-response relationship at voltage-clamped frog neuromuscular junctions.
    Dionne VE; Steinbach JH; Stevens CF
    J Physiol; 1978 Aug; 281():421-44. PubMed ID: 309004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in the sensitivity of the amphibian end-plate to acetylcholine and carbachol in low calcium medium.
    Okada K
    Yonago Acta Med; 1970 Aug; 14(2):53-60. PubMed ID: 5477864
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of hexamethonium and decamethonium on end-plate current parameters.
    Milne RJ; Byrne JH
    Mol Pharmacol; 1981 Mar; 19(2):276-81. PubMed ID: 6971989
    [No Abstract]   [Full Text] [Related]  

  • 44. Depolarizing action of Haliclona toxin on end-plate and muscle membranes.
    Wang CM; Narahashi T; Mende TJ
    Toxicon; 1973 Oct; 11(6):499-504. PubMed ID: 4543445
    [No Abstract]   [Full Text] [Related]  

  • 45. The antagonistic effects of calcium and potassium on the time course of action of carbamylcholine at the neuromuscular junction.
    Manthey AA
    J Membr Biol; 1972; 9(4):319-40. PubMed ID: 4539288
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of edrophonium on end-plate currents in frog skeletal muscle.
    Goldner MM; Narahashi T
    Eur J Pharmacol; 1974 Mar; 25(3):362-71. PubMed ID: 4545304
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of magnesium and calcium ions on post-tetanic increase in the frequency of miniature end-plate potentials in frog skeletal muscle].
    Kamenskaia MA; Puskaeva TD
    Biull Eksp Biol Med; 1972 Jun; 73(6):3-6. PubMed ID: 5050583
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of the "calcium ionophore" A-23187 on transmitter release at the frog neuromuscular junction.
    Kita H; Madden K; Van der Kloot W
    Life Sci; 1975 Dec; 17(12):1837-41. PubMed ID: 3706
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of indomethacin on quantal acetylcholine release at the frog neuromuscular junction.
    Madden KS; van der Kloot W
    Adv Prostaglandin Thromboxane Res; 1980; 8():1273-5. PubMed ID: 6246778
    [No Abstract]   [Full Text] [Related]  

  • 50. Proceedings: Drug concentration-conductance curves at frog end-plates determined by voltage-clamp.
    Adams PR
    J Physiol; 1974 Aug; 241(1):7P-8P. PubMed ID: 4419357
    [No Abstract]   [Full Text] [Related]  

  • 51. Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies.
    Ikeda SR; Aronstam RS; Daly JW; Aracava Y; Albuquerque EX
    Mol Pharmacol; 1984 Sep; 26(2):293-303. PubMed ID: 6090884
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The mode of action of batrachotoxin.
    Albuquerque EX
    Fed Proc; 1972; 31(3):1133-8. PubMed ID: 4338110
    [No Abstract]   [Full Text] [Related]  

  • 53. Estimates on magnitude of nonlinear summation of evoked potentials at motor end plate.
    Miyamoto MD
    J Neurophysiol; 1978 May; 41(3):589-99. PubMed ID: 307050
    [No Abstract]   [Full Text] [Related]  

  • 54. Modification of the nicotine-induced depolarization in striated muscle by altered (H + ) 0, (Ca ++ ) 0 and (Cl - ) 0 .
    Henderson EG; Reynolds L
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(1):81-90. PubMed ID: 4267968
    [No Abstract]   [Full Text] [Related]  

  • 55. Postsynaptic inhibition of neuromuscular transmission by trifluoperazine.
    Cheng KC; Lambert JJ; Henderson EG; Smilowitz H; Epstein PM
    J Pharmacol Exp Ther; 1981 Apr; 217(1):44-50. PubMed ID: 6259329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure-activity relationships of amantadine. I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane.
    Warnick JE; Maleque MA; Bakry N; Eldefrawi AT; Albuquerque EX
    Mol Pharmacol; 1982 Jul; 22(1):82-93. PubMed ID: 6126806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Org. 6368: a nondepolarizing neuromuscular blocking agent with a novel effect on end-plate conductance.
    Durant NN; Horn R
    J Pharmacol Exp Ther; 1984 Mar; 228(3):567-72. PubMed ID: 6608583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanism of nicotinic channel activation and blockade.
    Albuquerque EX; Adler M; Spivak CE; Aguayo L
    Ann N Y Acad Sci; 1980; 358():204-38. PubMed ID: 6259990
    [No Abstract]   [Full Text] [Related]  

  • 59. Quantitating cholinergic receptor molecules.
    Barnard EA
    Neurosci Res Program Bull; 1973 Jun; 11(3):231-6. PubMed ID: 4197761
    [No Abstract]   [Full Text] [Related]  

  • 60. The pharmacology of batrachotoxin. IV. Interaction with tetrodotoxin on innervated and chronically denervated rat skeletal muscle.
    Albuquerque EX; Warnick JE
    J Pharmacol Exp Ther; 1972 Mar; 180(3):683-97. PubMed ID: 5012787
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.